Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance

World Journal of Gastroenterology

Volumn 9, Issue 3, 2003, Pages 427-431

  Shao, Jin Chen ^b   Wu, Ji Feng ^a   Wang, Dao Bin ^a   Qin, Rong ^a   Zhang, Hong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SHANGHAI CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLINE; MESSENGER RNA; PROTEIN P53; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; GENDER; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; MORPHOLOGY; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; TUMOR DIFFERENTIATION;

EID: 0037348043     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i3.427     Document Type: Article

References (37)

1. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, Shay JW., Matsuura Y., Yokoyama T. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997; 57: 326-331
2. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Li S, West MD, Harely CB, Andrews WH, Greider CW, Villeponteau B. The RNA component of human telomerase. Science 1995; 269: 1236-1241
3. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MF, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785-795
4. Smith S, Giriat I, Schmitt A, De Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomerase. Science 1998; 282: 1484-1487
5. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO. A mammallian telomerase-associated protein. Science 1997; 275: 973-977
6. Jong HS, Park YI, Kim S, Sohn JH, Kang SH, Song SH, Bang YJ, Kim NK. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 1999; 86: 559-565
7. Meyerson M. Telomerase enzyme activation and human cell immortalization. Toxicol Lett 1998; 102-103: 41-45
8. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998; 58: 1558-1561
9. Vaziri H, Benchimol S. From telomerase loss to P53 induction and activation of a DNA-damage pathway at senescence: The telomere loss/DNA damage model of cell aging. Exp Gerontol 1996; 31: 295-301
10. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, Englezou A, Warneford SG, Dalla-Pozza L, Reddel RR. Alterations in P53 and P16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 1995; 15: 4745-4753
11. Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, Dhingra U, Sokoloski HA, Hsiao R, Narayanan R. Cell cycle-dependent modulation of telomerse activity in tumor cells. Proc Natl Acad Sci USA 1996; 93: 6091-6095
12. Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR. Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis? Hum Pathol 1993; 24: 469-476
13. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-3262
14. Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT, Narayanan R. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 1995; 92: 12343-12346
15. Yuan X, Zhang B, Ying J, Jin Y, Hou L. Expression of telomerase gene in human tumor tissues. Zhonghua Binglixue Zazhi 2000; 29: 16-19
16. Ahn MJ, Noh YH, Lee YS, Lee JH, Chung TJ, Kim IS, Choi IY, Kim SH, Lee JS, Lee KH. Telomerase activity and its clinicopathological significance in gastric cancer. Eur J Cancer 1997; 33: 1309-1313
17. Yang SM, Fang DC, Luo YH, Lu R, Yang JL, Liu WW. The detection of telomerase activity and subunit in different lesions of gastric mucosa. Aizheng 2001; 20: 23-27
18. Zhan WH, Ma JP, Peng JS, Gao JS, Cai SR, Wang JP, Zheng ZQ, Wang L. Telomerase activity in gastric cancer and its clinical implications. World J Gastroenterol 1999; 5: 316-319
19. Yao XX, Yin L, Sun ZC. The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis. World J Gastroenterol 2002; 8: 586-590
20. Clurman BE, Roberts JM. Cell cycle and cancer. J Natl Cancer Inst 1995; 87: 1499-1501
21. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440
22. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707.
23. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816
24. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825
25. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82: 675-684
26. Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, ElDeiry WS. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 1997; 389: 187-190
27. Liu Y, Martindale JL, Gorospe M, Holbrook NJ. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 1996; 56: 31-35
28. Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, Chella A, Merlo G, Angeletti CA, Dalla Palma P, Bevilacqua G. p21 RNA and protein expression in non-small cell lung carcinomas: Evidence of p53-independent expression and association with tumoral differentiation. Oncogene 1996; 12: 1319-1324
29. Greenblatt MS, Benett WP, Hollstein M, Harris CC. Mutations in the P53 tumor suppressor gene: Clues to cancer etiology and moleculas pathogenesis. Cancer Res 1994; 54: 4855-4878
30. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-1677
31. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55: 4525-4530
32. Velculescu VE, El-Deiry WS. Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem 1996; 42: 858-868
33. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 1994; 265: 346-355
34. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, Louis DN, Li FP, Rheinwald JG. Human keratinocytes that express hTRT and also bypass a P16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000; 20: 1436-1447
35. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J, Roos G. Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res 1997; 57: 549-554
36. Balasubramanian S, Kim KH, Ahmad N, Mukhtar H. Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorgenesis in SKH-1 hairless mouse. Oncogene 1999; 18: 1297-1302
37. Li H, Cao Y, Berndt MC, Funder JW, Liu JP. Molecular interactions between telomerase and the tumor suppressor protein P53 in vitro. Oncogene 1999; 18: 6785-6794